193 related articles for article (PubMed ID: 12196020)
1. X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-huperzine A and (-)-huperzine B: structural evidence for an active site rearrangement.
Dvir H; Jiang HL; Wong DM; Harel M; Chetrit M; He XC; Jin GY; Yu GL; Tang XC; Silman I; Bai DL; Sussman JL
Biochemistry; 2002 Sep; 41(35):10810-8. PubMed ID: 12196020
[TBL] [Abstract][Full Text] [Related]
2. 3D structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 A resolution: kinetic and molecular dynamic correlates.
Dvir H; Wong DM; Harel M; Barril X; Orozco M; Luque FJ; Muñoz-Torrero D; Camps P; Rosenberry TL; Silman I; Sussman JL
Biochemistry; 2002 Mar; 41(9):2970-81. PubMed ID: 11863435
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
[TBL] [Abstract][Full Text] [Related]
4. Binding of 13-amidohuprines to acetylcholinesterase: exploring the ligand-induced conformational change of the gly117-gly118 peptide bond in the oxyanion hole.
Camps P; Gómez E; Muñoz-Torrero D; Badia A; Clos MV; Curutchet C; Muñoz-Muriedas J; Luque FJ
J Med Chem; 2006 Nov; 49(23):6833-40. PubMed ID: 17154513
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica.
Kryger G; Silman I; Sussman JL
J Physiol Paris; 1998; 92(3-4):191-4. PubMed ID: 9789806
[TBL] [Abstract][Full Text] [Related]
6. Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug ganstigmine (CHF-2819).
Bartolucci C; Siotto M; Ghidini E; Amari G; Bolzoni PT; Racchi M; Villetti G; Delcanale M; Lamba D
J Med Chem; 2006 Aug; 49(17):5051-8. PubMed ID: 16913695
[TBL] [Abstract][Full Text] [Related]
7. The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.
Ariel N; Ordentlich A; Barak D; Bino T; Velan B; Shafferman A
Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):95-102. PubMed ID: 9742217
[TBL] [Abstract][Full Text] [Related]
8. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.
Kryger G; Silman I; Sussman JL
Structure; 1999 Mar; 7(3):297-307. PubMed ID: 10368299
[TBL] [Abstract][Full Text] [Related]
9. Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases.
Saxena A; Qian N; Kovach IM; Kozikowski AP; Pang YP; Vellom DC; Radić Z; Quinn D; Taylor P; Doctor BP
Protein Sci; 1994 Oct; 3(10):1770-8. PubMed ID: 7849595
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
[TBL] [Abstract][Full Text] [Related]
11. How does huperzine A enter and leave the binding gorge of acetylcholinesterase? Steered molecular dynamics simulations.
Xu Y; Shen J; Luo X; Silman I; Sussman JL; Chen K; Jiang H
J Am Chem Soc; 2003 Sep; 125(37):11340-9. PubMed ID: 16220957
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of Huperzine A Dissociation from Acetylcholinesterase via Multiple Unbinding Pathways.
Rydzewski J; Jakubowski R; Nowak W; Grubmüller H
J Chem Theory Comput; 2018 Jun; 14(6):2843-2851. PubMed ID: 29715428
[TBL] [Abstract][Full Text] [Related]
13. Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: Binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge.
Rydberg EH; Brumshtein B; Greenblatt HM; Wong DM; Shaya D; Williams LD; Carlier PR; Pang YP; Silman I; Sussman JL
J Med Chem; 2006 Sep; 49(18):5491-500. PubMed ID: 16942022
[TBL] [Abstract][Full Text] [Related]
14. Structure of a complex of the potent and specific inhibitor BW284C51 with Torpedo californica acetylcholinesterase.
Felder CE; Harel M; Silman I; Sussman JL
Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1765-71. PubMed ID: 12351819
[TBL] [Abstract][Full Text] [Related]
15. Predicting relative binding free energies of tacrine-huperzine A hybrids as inhibitors of acetylcholinesterase.
Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Dec; 42(25):5110-9. PubMed ID: 10602696
[TBL] [Abstract][Full Text] [Related]
16. The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.
Greenblatt HM; Guillou C; Guénard D; Argaman A; Botti S; Badet B; Thal C; Silman I; Sussman JL
J Am Chem Soc; 2004 Dec; 126(47):15405-11. PubMed ID: 15563167
[TBL] [Abstract][Full Text] [Related]
17. Active-site gorge and buried water molecules in crystal structures of acetylcholinesterase from Torpedo californica.
Koellner G; Kryger G; Millard CB; Silman I; Sussman JL; Steiner T
J Mol Biol; 2000 Feb; 296(2):713-35. PubMed ID: 10669619
[TBL] [Abstract][Full Text] [Related]
18. Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method.
Kitisripanya N; Saparpakorn P; Wolschann P; Hannongbua S
Nanomedicine; 2011 Feb; 7(1):60-8. PubMed ID: 20851778
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of inhibition of cholinesterases by huperzine A.
Ashani Y; Peggins JO; Doctor BP
Biochem Biophys Res Commun; 1992 Apr; 184(2):719-26. PubMed ID: 1575745
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs.
Bartolucci C; Perola E; Pilger C; Fels G; Lamba D
Proteins; 2001 Feb; 42(2):182-91. PubMed ID: 11119642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
